fda warning letters compounded glp-1 september 2025 Beyond the Headlines: to Compounders Why the FDA Issued 30
Description
The combination of compounded GLP-1 therapy plus modest dietary optimization (including allulose if you prefer it) is the evidence-based approach
F.OgdenJ
Allulose can be used in beverages, baking, or as a tabletop sweetener, though its properties differ slightly from sucrose in cooking applications
Dual GIP/GLP-1 receptor co-agonists The discovery of the first GIP/GLP-1 receptor co-agonist was reported in 2013 [74]
GLP-1 dose context is not the center of the experience there
